Trial Participant Tax Compliance Is A Serious Burden — Make It Ours

The complexity of tax compliance in clinical trials has evolved from a back-office administrative task into a significant barrier to patient diversity and trial retention. For many participants, trial stipends can inadvertently jeopardize eligibility for essential public assistance programs such as SNAP and Medicaid. When compensation is flagged as taxable income, the fear of losing benefits can lead to early withdrawal or a refusal to enroll, stalling medical progress and skewing data.

Navigating these regulations requires a strategic shift in how payments are structured. By prioritizing the reimbursement of out-of-pocket expenses—which are typically non-taxable—over flat stipends, study teams can drastically reduce tax exposure for participants. Furthermore, adopting a centralized payment model allows sponsors and sites to offload the legal and operational liability of global tax reporting. Shifting this burden away from the clinical site ensures that researchers can focus on science rather than shifting tax thresholds, while simultaneously dismantling the financial deterrents that keep patients from contributing to life-changing research.